| Serial Number | 97077402 |
| Word Mark | CIMPLRX |
| Filing Date | Friday, October 15, 2021 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, September 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 15, 2024 |
| Goods and Services | Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software |
| Goods and Services | New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 4, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cimplrx Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seocho-gu, Seoul 06764 KR |
| Event Date | Event Description |
| Tuesday, October 19, 2021 | NEW APPLICATION ENTERED |
| Thursday, November 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 21, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, July 26, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 26, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 25, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 25, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 26, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 21, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, February 21, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, February 21, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, September 7, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, September 7, 2023 | SUSPENSION INQUIRY WRITTEN |
| Thursday, September 7, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, September 7, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, January 26, 2024 | ASSIGNED TO LIE |
| Friday, January 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 16, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 13, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |